Strategy's convertible debt, valued at $8.2 billion, now has a $5.2 billion market premium as its stock price approaches $450 ...

The shares of Biocon rose over 1% during trade so far. The scrip had risen as much as 3.96% and is currently trading 1.31% higher at Rs 395. The scrip was trading higher and gains compare to a 0.21% ...

Indian equity benchmarks edged lower on Wednesday, mirroring weakness in Asian markets following a rise in US inflation.